Form D · Other Health Care

ImmunSYS, Inc.

Fort Lauderdale, FL · CIK 0001749655

Offering snapshot reported Apr 20, 2020 · SEC filing

Reported sold
$283K
Offering amount: $2M
Investors reported
9
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 15, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 20, 2020Initial$283,270No comparison9SEC filing
Oct 3, 2019Amendment$5,200,432$4,523,880vs Aug 15, 201835SEC filing
Aug 15, 2018Initial$676,552No comparison3SEC filing

Offering details

Securities
Debt, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-365387
Convertible promissory notes

Source: Form D, filed Apr 20, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jeffrey L. Cleland Director
Jon H. Condra Executive
Agustin Gago Executive
Joseph G. Gerardi Executive
Eamonn P. Hobbs Director, Executive
Charles J. Link Director, Executive
Joseph C. Maroon Director
Gary A. Onik Director, Executive
Dan Recinella Executive
Norman D. Schwartz Director
David Vaughan Executive
Douglas G. Watson Director
Marlene Wright Barton Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
2804 Ne 30th St
Fort Lauderdale, FL, 33306